Source-based interaction record

Beloc ZOK 25 mg + Xatral XL 10 mg Denetimli Salımlı Tablet

Beloc ZOK 25 mg + Xatral XL 10 mg Denetimli Salımlı Tablet: published drug interaction record, medicine facts and reference links. Generic / active ingredient: Metoprolol + Alfuzosin.

Free preview

Essential record information

Public access

Free record overview for Beloc ZOK 25 mg + Xatral XL 10 mg Denetimli Salımlı Tablet. Review the medicine identities and available reference links below; detailed interaction information is in the access section.

Beloc ZOK 25 mg

Active ingredient / generic name: Metoprolol
ATC code: C07AB02

Xatral XL 10 mg Denetimli Salımlı Tablet

Active ingredient / generic name: Alfuzosin
ATC code: G04CA01

Record type: Published interaction record
Source record version: Xatral XL SmPC PL04425/0657; 15/10/2024

Record sources

Original interaction source (recorded provenance) (opens in a new tab)

Source checked: 2026-10-26

A source check is not an independent clinical review.

Access to this record

Free preview: Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details: The selected pair’s available detailed interaction explanation, mechanism and clinical context can be read with single-page access or an eligible membership page allowance.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

This page only: 6.00 USD One-time payment
Monthly membership: 40.00 USD / month · starting price

A free account with a verified email address is required before checkout. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.

Published related records: 164. The selection below does not represent the complete list.

Informational

Beloc ZOK 25 mg + Desvenlafaxine

Recorded classification; this selection is not a full list or a conclusion that use is safe.

www.pfizermedical.com Source checked: 2026-10-30

View record

Minor

Beloc ZOK 25 mg + Imatinib

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Minor

Beloc ZOK 25 mg + Kaptoril 25 mg Tablet

Recorded classification; this selection is not a full list or a conclusion that use is safe.

deva.com.tr Source checked: 2026-10-15

View record

Details of this record

Access this interaction record

Basic facts and available reference links are free. The headings below identify the paid details present in this record; clinical content is read after access is unlocked.

Sections available in this record

Interaction mechanism
Interaction explanation

Review the free record and source informationSource checked: 2026-10-26

This page only

6.00 USDOne-time payment

Permanent access to this record and its available language versions. No subscription required.

For returning to one record. No monthly subscription.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

30 different records per billing period. Reading a record again in the same period does not use another page allowance.

For exploring multiple records. Pages unlocked with membership are readable during that billing period.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

Check medicine interactions

Results show the recorded information for the two medicines. A missing record does not mean there is no interaction.

Results open in English when available, otherwise in Turkish. Each record keeps its own access requirements.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.